Osaic Holdings’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $75.6K | Buy |
2,122
+813
| +62% | +$28.9K | ﹤0.01% | 4382 |
|
2025
Q1 | $45.3K | Sell |
1,309
-1,921
| -59% | -$66.4K | ﹤0.01% | 4774 |
|
2024
Q4 | $86.4K | Sell |
3,230
-15,514
| -83% | -$415K | ﹤0.01% | 4282 |
|
2024
Q3 | $477K | Sell |
18,744
-1,044
| -5% | -$26.6K | ﹤0.01% | 2909 |
|
2024
Q2 | $501K | Buy |
19,788
+1,918
| +11% | +$48.6K | ﹤0.01% | 2767 |
|
2024
Q1 | $552K | Buy |
17,870
+2,024
| +13% | +$62.6K | ﹤0.01% | 2852 |
|
2023
Q4 | $639K | Buy |
15,846
+13,489
| +572% | +$544K | ﹤0.01% | 2946 |
|
2023
Q3 | $62.1K | Buy |
2,357
+134
| +6% | +$3.53K | ﹤0.01% | 4830 |
|
2023
Q2 | $38.2K | Buy |
2,223
+178
| +9% | +$3.06K | ﹤0.01% | 5108 |
|
2023
Q1 | $33.9K | Buy |
2,045
+235
| +13% | +$3.9K | ﹤0.01% | 5209 |
|
2022
Q4 | $13K | Sell |
1,810
-45
| -2% | -$323 | ﹤0.01% | 5777 |
|
2022
Q3 | $18K | Sell |
1,855
-86
| -4% | -$835 | ﹤0.01% | 5625 |
|
2022
Q2 | $18K | Buy |
1,941
+132
| +7% | +$1.22K | ﹤0.01% | 5655 |
|
2022
Q1 | $18K | Buy |
1,809
+83
| +5% | +$826 | ﹤0.01% | 5727 |
|
2021
Q4 | $28K | Sell |
1,726
-281
| -14% | -$4.56K | ﹤0.01% | 5531 |
|
2021
Q3 | $94K | Hold |
2,007
| – | – | ﹤0.01% | 4577 |
|
2021
Q2 | $122K | Buy |
2,007
+341
| +20% | +$20.7K | ﹤0.01% | 4305 |
|
2021
Q1 | $102K | Sell |
1,666
-122
| -7% | -$7.47K | ﹤0.01% | 4312 |
|
2020
Q4 | $127K | Buy |
1,788
+483
| +37% | +$34.3K | ﹤0.01% | 3864 |
|
2020
Q3 | $49K | Hold |
1,305
| – | – | ﹤0.01% | 4303 |
|
2020
Q2 | $43K | Buy |
1,305
+475
| +57% | +$15.7K | ﹤0.01% | 4268 |
|
2020
Q1 | $24K | Buy |
+830
| New | +$24K | ﹤0.01% | 4461 |
|